CTLA4 and neoplasm: Similarly, cyclophosphamide administered 1 day before could enhance the antitumor effect of anti-CTLA4 antibody, whereas, treatment with the reversed-sequence regimen led to the apoptosis of proliferating tumor-specific CD8+ T cells and then attenuated tumor control [160].